1. Renal Function in Primary Liver Transplant Recipients Receiving Neoral (Cyclosporine) Versus Prograf (Tacrolimus)
- Author
-
J Payne, Sunil K. Geevarghese, R. E. Richie, MacDonell Rc, J.K Wright, J H Helderman, D. H. Van Buren, William C. Chapman, and C.W Pinson
- Subjects
Graft Rejection ,medicine.medical_specialty ,Time Factors ,Urology ,Renal function ,Kidney ,Tacrolimus ,Postoperative Complications ,Diabetes mellitus ,Azathioprine ,Diabetes Mellitus ,medicine ,Humans ,Prospective Studies ,Prospective cohort study ,Survival rate ,Analysis of Variance ,Transplantation ,business.industry ,Incidence ,Ciclosporin ,medicine.disease ,Liver Transplantation ,Surgery ,Survival Rate ,Creatinine ,Chemoprophylaxis ,Cyclosporine ,Prednisone ,Regression Analysis ,business ,Immunosuppressive Agents ,Follow-Up Studies ,medicine.drug - Abstract
Immunosuppressive efficacy of Neoral and Prograf following primary hepatic transplantation was comparable. Incidence of rejection episodes, infectious complications, hypertension, and postoperative diabetes mellitus was comparable. Although clinical use of both immunosuppressants was associated with early compromise in renal function, no progressive renal dysfunction was observed.
- Published
- 1998
- Full Text
- View/download PDF